MEDIUM‐DOSE METHOTREXATE/FOLINIC ACID REGIMEN IN THE CHEMOTHERAPY OF GESTATIONAL TROPHOBLASTIC DISEASE
- 1 April 1980
- journal article
- research article
- Published by AMPCo in The Medical Journal of Australia
- Vol. 1 (7) , 317-320
- https://doi.org/10.5694/j.1326-5377.1980.tb134881.x
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- The Beta‐Subunit of Chorionic Gonadotropin as a Tumour Marker in Gestational Trophoblastic DiseaseAustralian and New Zealand Journal of Obstetrics and Gynaecology, 1980
- Measurement of the Beta ‐ Subunit of Chorionic Gonadotrophin in Uncomplicated, Complicated, and Molar PregnanciesAustralian and New Zealand Journal of Obstetrics and Gynaecology, 1977
- Lessons from ChoriocarcinomaProceedings of the Royal Society of Medicine, 1977
- Risk and prognostic factors in trophoblastic neoplasiaCancer, 1976
- Actinomycin D as the primary agent for gestational trophoblastic diseaseCancer, 1975
- Methotrexate for prophylaxis of choriocarcinomaAmerican Journal of Obstetrics and Gynecology, 1971
- FIVE YEARS?? EXPERIENCE WITH THE PREVENTION OF TROPHOBLASTIC TUMORS BY THE PROPHYLACTIC USE OF CHEMOTHERAPY IN PATIENTS WITH MOLAR PREGNANCYClinical Obstetrics and Gynecology, 1970
- Pregnancies after Chemotherapy of Trophoblastic NeoplasmsScience, 1970
- ChoriocarcinomaAmerican Journal of Obstetrics and Gynecology, 1963
- Effect of Methotrexate Therapy upon Choriocarcinoma and ChorioadenomaExperimental Biology and Medicine, 1956